| Literature DB >> 21048851 |
Sumanta Chatterjee1, Pratima Basak, Prosun Das, Madhurima Das, Jacintha Archana Pereira, Ranjan Kumar Dutta, Malay Chaklader, Samaresh Chaudhuri, Sujata Law.
Abstract
Self-renewing Hematopoietic Stem Cells (HSCs) are responsible for reconstitution of all blood cell lineages. Sca-1 is the "stem cell antigen" marker used to identify the primitive murine HSC population, the expression of which decreases upon differentiation to other mature cell types. Sca-1(+) HSCs maintain the bone marrow stem cell pool throughout the life. Aplastic anemia is a disease considered to involve primary stem cell deficiency and is characterized by severe pancytopenia and a decline in healthy blood cell generation system. Studies conducted in our laboratory revealed that the primitive Sca-1(+) BM-HSCs (bone marrow hematopoietic stem cell) are significantly affected in experimental Aplastic animals pretreated with chemotherapeutic drugs (Busulfan and Cyclophosphamide) and there is increased Caspase-3 activity with consecutive high Annexin-V positivity leading to premature apoptosis in the bone marrow hematopoietic stem cell population in Aplastic condition. The Sca-1(bright), that is, "more primitive" BM-HSC population was more affected than the "less primitive" BM-HSC Sca-1(dim ) population. The decreased cell population and the receptor expression were directly associated with an empty and deranged marrow microenvironment, which is evident from scanning electron microscopy (SEM). The above experimental evidences hint toward the manipulation of receptor expression for the benefit of cytotherapy by primitive stem cell population in Aplastic anemia cases.Entities:
Year: 2009 PMID: 21048851 PMCID: PMC2963143 DOI: 10.4061/2010/614395
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Peripheral blood hemogram showed a depressed hemoglobin level with uniformly reduced corpuscular counts, of which reticulocyte counts are significantly low (≤0.2) in Aplastic groups compared with the normal range. The total WBC and Neutrophil counts were also found to be significantly low in the diseased group compared to the normal.
| Parameters | Normal control groups (Mean ± SD) | Aplastic anemic groups (Mean ± SD) |
|---|---|---|
| Hemoglobin (g/dL) | 15.99 ± 0.26 | 9.08 ± 0.47 |
| WBC (x 103/ | 6.2 ± 1.28 | 2.7 ± 0.68 |
| RBC (x 106/ | 8.44 ± 0.32 | 3.8 ± 0.86 |
| Platelets (x 103/ | 432 ± 13.82 | 198 ± 14.36 |
| Reticulocyte(%) | 0.89 ± 0.15 | 0.18 ± 0.07 |
| Neutrophil(%) | 22.75 ± 2.21 | 7.35 ± 2.75 |
Figure 1(a) Gated region of flowcytometric analysis. (b) Phenotypic characterization of Sca-1 expression by normal bone marrow cells. R-1 region indicates the Sca-1dim population (8.83%). R-2 region indicates the Sca-1bright population (12.23%). (c) Phenotypic characterization of Sca-1 expression by Aplastic anemic bone marrow cells. R-2 region, that is, Sca-1bright population is more severely affected (0.01%) compared to the Sca-1dim population in the R-1 region.
Figure 2(a) Annexin-V positivity shown by Sca-1+ bone marrow cells in normal condition (0.46%). (b) Annexin-V positivity shown by Sca-1+ bone marrow cells in Aplastic anemia (3.05%) is much higher compared to the normal.
Figure 3Caspase-3 activity showed by BM-HSCs in Aplastic anemia (49% ± 2.34%) (P < .05) was significantly higher compared to that of the normal counterpart (2.6% ± 0.31%) (P < .01).
Figure 4(a) Leishman staining of bone marrow smear showing densely packed cellular distribution in normal condition. (b) Leishman staining of Aplastic bone marrow smear exhibiting frequent appearance of large fat cells (adipocytes) with empty spaces.
Figure 5(a) Scanning electron microscopy of normal bone marrow. (b) Scanning electron microscopy of Aplastic bone marrow exhibit an overall scanty and degenerative marrow and other cellular components compared to the normal marrow.